Murakami Yoshiki, Kawada Norifumi
Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Hepatol Res. 2017 Jan;47(1):60-69. doi: 10.1111/hepr.12730. Epub 2016 Jun 4.
MicroRNAs (miRNAs) are a group of small non-coding RNAs that range in length from 20 to 25 nucleotides. MicroRNAs are specific for multiple cellular functions, including cell generation, differentiation, multiplication, carcinogenesis, and apoptosis. Many researchers have recently reported that the aberrant expression of miRNAs in hepatic tissue was related to the pathogenesis of liver disease, including viral hepatitis, hepatocellular carcinoma, and fatty liver disease. Multiple studies have proposed that an analysis of circulating miRNAs may be useful for diagnosing etiologies or staging the progression of liver disease, as well as for therapeutic purposes, for example, nucleic acid therapy. This review summarizes and discusses recent advances in the knowledge of miRNAs for chronic liver diseases, with special interest in viral hepatitis, liver fibrosis, and biomarkers.
微小RNA(miRNA)是一组长度为20至25个核苷酸的小型非编码RNA。微小RNA对多种细胞功能具有特异性,包括细胞生成、分化、增殖、致癌作用和细胞凋亡。最近许多研究人员报告说,肝组织中miRNA的异常表达与肝病的发病机制有关,包括病毒性肝炎、肝细胞癌和脂肪性肝病。多项研究提出,分析循环miRNA可能有助于诊断肝病的病因或分期疾病进展,以及用于治疗目的,例如核酸治疗。本综述总结并讨论了关于慢性肝病的miRNA知识的最新进展,特别关注病毒性肝炎、肝纤维化和生物标志物。